News
A doctor has urged patients to proceed with caution when using cannabis during cancer immunotherapy and called for more ...
Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of ...
A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, ...
New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...
David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...
A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune ...
A breakthrough AI system is revolutionizing cancer immunotherapy by enabling scientists to design protein-based keys that ...
Some lung cancers do not respond well to immunotherapy, a treatment that helps the body’s immune system attack cancer. But a new study shows that radiation therapy might help solve this problem. The ...
Weill Cancer Hub West will harness genomics, big data, AI, and machine learning to counter California’s 20 new cancer cases ...
Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...
Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.
During a live event, Bruna Pellini, MD, discussed the efficacy of cemiplimab in PD-L1-high non–small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results